Implanet S.A. (EPA: ALIMP)

Market Cap	13.68M
Revenue (ttm)	7.30M
Net Income (ttm)	-6.06M
Shares Out	124.97M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107,898
Open	0.109
Previous Close	0.115
Day's Range	0.109 - 0.120
52-Week Range	0.060 - 0.168
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 6, 2025

About Implanet

Implanet S.A., a medical technology company, manufactures and sells implants for orthopedic surgery. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. The company was founded in 2006 and is based in Martillac, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 41
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2023, Implanet's revenue was 7.45 million, a decrease of -7.24% compared to the previous year's 8.03 million. Losses were -6.68 million, 88.6% more than in 2022.